Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting Hepatic Glutaminase 1 Ameliorates Non-alcoholic Steatohepatitis by Restoring Very-Low-Density Lipoprotein Triglyceride Assembly
Jorge Simón, Maitane Núñez-García, Pablo Fernández‐Tussy, et al.
Cell Metabolism (2020) Vol. 31, Iss. 3, pp. 605-622.e10
Open Access | Times Cited: 100

Showing 26-50 of 100 citing articles:

Associations between circulating amino acids and metabolic dysfunction‐associated steatotic liver disease in individuals living with severe obesity
Ina Maltais‐Payette, Jérôme Bourgault, Marie‐Frédérique Gauthier, et al.
Physiological Reports (2025) Vol. 13, Iss. 3
Open Access
The role of liver sinusoidal endothelial cells in metabolic dysfunction-associated steatotic liver diseases and liver cancer: mechanisms and potential therapies
Hanjun Mo, Pengfei Yue, Qiaoqi Li, et al.
Angiogenesis (2025) Vol. 28, Iss. 2
Closed Access
Expression pattern of glutaminase informs the dynamics of glutamine metabolism
Dingxue Hu, Wanqiu Wang, Xin Zhao, et al.
The Innovation Life (2025), pp. 100128-100128
Closed Access
Estimated sdLDL-C as a biomarker of hepatic steatosis severity in MASLD: a retrospective study
Shu Jiang, Fan Zhang, Huixia Yang, et al.
BMC Gastroenterology (2025) Vol. 25, Iss. 1
Open Access
Endoplasmic reticulum stress and autophagy dysregulation in alcoholic and non-alcoholic liver diseases
Yun Seok Kim, Sang Geon Kim
Clinical and Molecular Hepatology (2020) Vol. 26, Iss. 4, pp. 715-727
Open Access | Times Cited: 43
Tumor metabolic reprogramming in lung cancer progression (Review)
Xin Li, Minghui Liu, Hongyu Liu, et al.
Oncology Letters (2022) Vol. 24, Iss. 2
Open Access | Times Cited: 25
Integrating the contributions of mitochondrial oxidative metabolism to lipotoxicity and inflammation in NAFLD pathogenesis
Curtis C. Hughey, Patrycja Puchalska, Peter A. Crawford
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids (2022) Vol. 1867, Iss. 11, pp. 159209-159209
Closed Access | Times Cited: 22
The spike of SARS-CoV-2 promotes metabolic rewiring in hepatocytes
María Mercado-Gómez, Endika Prieto‐Fernández, Naroa Goikoetxea‐Usandizaga, et al.
Communications Biology (2022) Vol. 5, Iss. 1
Open Access | Times Cited: 22
Tetrahydropalmatine ameliorates hepatic steatosis in nonalcoholic fatty liver disease by switching lipid metabolism via AMPK-SREBP-1c-Sirt1 signaling axis
Xunzhe Yin, Zuojia Liu, Jin Wang
Phytomedicine (2023) Vol. 119, pp. 155005-155005
Closed Access | Times Cited: 14
Theabrownin ameliorates liver inflammation, oxidative stress, and fibrosis in MCD diet-fed C57BL/6J mice
Qingcai Zhen, Qijian Liang, Hongchun Wang, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 13
Long-term and liver-selected ginsenoside C–K nanoparticles retard NAFLD progression by restoring lipid homeostasis
Chunyan Yue, Dandan Li, Shuxin Fan, et al.
Biomaterials (2023) Vol. 301, pp. 122291-122291
Closed Access | Times Cited: 12
Glutamine Mitigates Oxidative Stress-Induced Matrix Degradation, Ferroptosis, and Pyroptosis in Nucleus Pulposus Cells via Deubiquitinating and Stabilizing Nrf2
Jiajun Wu, Weitao Han, Yangyang Zhang, et al.
Antioxidants and Redox Signaling (2024) Vol. 41, Iss. 4-6, pp. 278-295
Closed Access | Times Cited: 4
Remodeling Intestinal Microbiota Alleviates Severe Combined Hyperlipidemia-Induced Nonalcoholic Steatohepatitis and Atherosclerosis in LDLR -/- Hamsters
Guolin Miao, Jiabao Guo, Wenxi Zhang, et al.
Research (2024) Vol. 7
Open Access | Times Cited: 4
Protocol for pull-down capture of ubiquitinated and NEDDylated liver proteins from transgenic biotinylated ubiquitin and NEDD8 mice
L. Estefanía Zapata-Pavas, Teresa C. Delgado, María Luz Martínez‐Chantar
STAR Protocols (2025) Vol. 6, Iss. 2, pp. 103697-103697
Closed Access
Magnesium accumulation upon cyclin M4 silencing activates microsomal triglyceride transfer protein improving NASH
Jorge Simón, Naroa Goikoetxea‐Usandizaga, Marina Serrano‐Maciá, et al.
Journal of Hepatology (2021) Vol. 75, Iss. 1, pp. 34-45
Open Access | Times Cited: 28
Metabolomic profiling of pancreatic adenocarcinoma reveals key features driving clinical outcome and drug resistance
Abdessamad El Kaoutari, Nicolás A. Fraunhoffer, Owen Hoare, et al.
EBioMedicine (2021) Vol. 66, pp. 103332-103332
Open Access | Times Cited: 27
Preventive Effects of Different Black and Dark Teas on Obesity and Non-Alcoholic Fatty Liver Disease and Modulate Gut Microbiota in High-Fat Diet Fed Mice
Bangyan Li, Qianqian Mao, Ruo-Gu Xiong, et al.
Foods (2022) Vol. 11, Iss. 21, pp. 3457-3457
Open Access | Times Cited: 19
Eight Zhes Decoction ameliorates the lipid dysfunction of nonalcoholic fatty liver disease using integrated lipidomics, network pharmacology and pharmacokinetics
Yuping Zhou, Ze Dai, Kaili Deng, et al.
Journal of Pharmaceutical Analysis (2023) Vol. 13, Iss. 9, pp. 1058-1069
Open Access | Times Cited: 11
Unexpected omega-3 activities in intracellular lipolysis and macrophage foaming revealed by fluorescence lifetime imaging
H. S. Tang, Zhengjie Liu, Guangmei Han, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 15
Closed Access | Times Cited: 3
Roles and Mechanisms of Choline Metabolism in Nonalcoholic Fatty Liver Disease and Cancers
Xin Chen, Wenying Qiu, Xuqian Ma, et al.
Frontiers in Bioscience-Landmark (2024) Vol. 29, Iss. 5
Open Access | Times Cited: 3
Drivers of cardiovascular disease in metabolic dysfunction-associated steatotic liver disease: the threats of oxidative stress
Erika Minetti, Naomi M. Hamburg, Reiko Matsui
Frontiers in Cardiovascular Medicine (2024) Vol. 11
Open Access | Times Cited: 3
A Shortcut from Metabolic-Associated Fatty Liver Disease (MAFLD) to Hepatocellular Carcinoma (HCC): c-MYC a Promising Target for Preventative Strategies and Individualized Therapy
Feifei Guo, Olga Estévez‐Vázquez, Raquel Benedé‐Ubieto, et al.
Cancers (2021) Vol. 14, Iss. 1, pp. 192-192
Open Access | Times Cited: 25
Steatotic Hepatocytes Release Mature VLDL Through Methionine and Tyrosine Metabolism in a Keap1‐Nrf2–Dependent Manner
Akitoshi Sano, Eiji Kakazu, Shin Hamada, et al.
Hepatology (2021) Vol. 74, Iss. 3, pp. 1271-1286
Closed Access | Times Cited: 23
Hepatocyte-specific deletion of Nlrp6 in mice exacerbates the development of non-alcoholic steatohepatitis
Cuiyuan Huang, Qinhui Liu, Qin Tang, et al.
Free Radical Biology and Medicine (2021) Vol. 169, pp. 110-121
Closed Access | Times Cited: 23
Integration of transcriptomics and metabonomics revealed the protective effects of hemp seed oil against methionine–choline-deficient diet-induced non-alcoholic steatohepatitis in mice
Mengjuan Gong, Hailong Lu, Lixi Li, et al.
Food & Function (2023) Vol. 14, Iss. 4, pp. 2096-2111
Closed Access | Times Cited: 9

Scroll to top